Notably, studies have demonstrated that administering anti-FGF23 treatment can ameliorate hypophosphatemia and rickets in young mice with X-linked hypophosphatemia (XLH), while also increasing muscle strength and spontaneous motor activity in adult XLH mice [179]. Here, FGF23 is linked to rickets.